SHENKMAN CAPITAL MANAGEMENT INC - TEVA PHARMACEUTICAL FIN LLC ownership

TEVA PHARMACEUTICAL FIN LLC's ticker is and the CUSIP is 88163VAE9. A total of 52 filers reported holding TEVA PHARMACEUTICAL FIN LLC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
SHENKMAN CAPITAL MANAGEMENT INC ownership history of TEVA PHARMACEUTICAL FIN LLC
ValueSharesWeighting
Q1 2020$931,000
-69.5%
1,000,000
-70.4%
0.14%
-56.2%
Q3 2017$3,057,000
-76.1%
3,373,000
-71.6%
0.32%
-72.5%
Q2 2017$12,783,000
+0.4%
11,864,000
+0.5%
1.15%
+5.2%
Q1 2017$12,731,000
+19.2%
11,802,000
+21.5%
1.09%
+32.3%
Q4 2016$10,684,000
+5.0%
9,713,000
+14.4%
0.83%
+5.4%
Q3 2016$10,174,000
+0.1%
8,492,000
+5.2%
0.78%
-9.7%
Q2 2016$10,159,000
+10.2%
8,075,000
+14.4%
0.87%
+1.8%
Q1 2016$9,218,000
+11.5%
7,057,000
+33.9%
0.85%
+3.6%
Q4 2015$8,264,000
+41.6%
5,269,000
+22.8%
0.82%
+46.4%
Q3 2015$5,835,000
+39.3%
4,289,000
+43.3%
0.56%
+39.7%
Q2 2015$4,188,000
-60.2%
2,994,000
-57.8%
0.40%
-65.7%
Q1 2015$10,532,000
+3.2%
7,092,000
-4.8%
1.18%
+3.9%
Q4 2014$10,206,000
-6.8%
7,453,000
-12.5%
1.13%
-8.9%
Q3 2014$10,952,000
-2.3%
8,515,000
-2.3%
1.24%
-6.0%
Q2 2014$11,210,000
-13.3%
8,715,000
-13.8%
1.32%
-5.9%
Q1 2014$12,929,000
+0.4%
10,105,000
-16.1%
1.40%
+1.0%
Q4 2013$12,873,000
-26.2%
12,045,000
-28.2%
1.39%
-32.0%
Q3 2013$17,451,000
+14.2%
16,770,000
+14.6%
2.05%
+9.8%
Q2 2013$15,279,00014,630,0001.86%
Other shareholders
TEVA PHARMACEUTICAL FIN LLC shareholders Q2 2015
NameSharesValueWeighting ↓
ZAZOVE ASSOCIATES LLC 83,413,000$130,650,0006.13%
AEGON USA Investment Management, LLC 6,000,000$9,368,0002.35%
MACKAY SHIELDS LLC 24,370,000$38,152,0002.07%
INCOME RESEARCH & MANAGEMENT 4,374,000$6,829,0001.11%
KINGDON CAPITAL MANAGEMENT, L.L.C. 20,000$20,347,0000.99%
SHENKMAN CAPITAL MANAGEMENT INC 5,269,000$8,264,0000.82%
Mitsubishi UFJ Securities Holdings Co., Ltd. 325,000$511,0000.76%
PALISADE CAPITAL MANAGEMENT, LP 9,299,000$14,598,0000.47%
ADVENT CAPITAL MANAGEMENT /DE/ 14,543,000$23,021,0000.35%
CSS LLC/IL 3,750,000$5,893,0000.35%
View complete list of TEVA PHARMACEUTICAL FIN LLC shareholders